Trial Search

Current Search Criteria:

Intervention: Tranexamic Acid Injectable Product (1000 mg intravenous bolus)
Found 1 matching trials

Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery

EARLY_PHASE1

As tranexamic acid (TXA) becomes more prevalent, all patients are receiving...

Status

Recruiting

Location

Rush University Medical Center

Start Date

2019-08-26

Trial ID

NCT03849443

Treatments Being Tested

Tranexamic Acid Injectable Product (1000 mg intravenous bolus)Vitamin C 250 MG Oral TabletTranexamic Acid 650Mg Tablet
PreviousNext